Results 181 to 190 of about 211,355 (249)

Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate‐to‐Severe Atopic Dermatitis

Allergy, EarlyView.
Data were included from adolescents with moderate‐to‐severe AD treated with the JAK1 inhibitor abrocitinib (200 mg/100 mg) across JADE clinical trials. Improvements in skin clearance (per EASI‐75) and itch (per PP‐NRS4) were maintained for up to 112 weeks with both abrocitinib doses.
Amy S. Paller, Lawrence F. Eichenfield, Alan D. Irvine, Carsten Flohr, Andreas Wollenberg, Sébastien Barbarot, Christine Bangert, Jonathan M. Spergel, Andrew Selfridge, Pinaki Biswas, Haiyun Fan, Justine Alderfer, Melissa Watkins, Herwig Koppensteiner   +13 more
wiley   +1 more source

Anlotinib-associated pulmonary embolism in brainstem glioblastoma treatment: a case report. [PDF]

Front Oncol
Zhao JL, Zhang YL, Qu KJ, Jiang YY, Li JL, Zhou J, Wu ST, Li JW.   +7 more
europepmc   +1 more source

Non‐Allergic Urticarial Skin Reactions Associated With MOv18 IgE, a First‐In‐Class IgE Antibody Recognising Folate Receptor Alpha

Allergy, EarlyView.
MOv18 IgE, the first‐in‐class IgE antibody targeting the cancer antigen folate receptor alpha (FR⍺) showed early signs of efficacy and was well tolerated in a first‐in‐human clinical trial, with transient urticarial skin reactions as the most common toxicity.
Chara Stavraka, Jitesh Chauhan, Silvia Crescioli, Sheila M. McSweeney, Amy Pope, Cheryl Gillett, Ashley Di Meo, Ioannis Prassas, Roman Laddach, Katie Stoker, Alexandra J. McCraw, Rebecca Adams, Thomas J. Tull, Nabeel Naban, Zena Willsmore, Kristina V. Semkova, Clive E. H. Grattan, John McGrath, Stephen J. Till, Christopher J. Corrigan, Rebecca Kristeleit, Sophia Tsoka, Eleftherios P. Diamandis, Katie E. Lacy, Sarah Pinder, Debra H. Josephs, James Spicer, Heather J. Bax, Sophia N. Karagiannis   +28 more
wiley   +1 more source

Characteristics and Outcomes of Pulmonary Embolism Patients Transferred After Activation of Pulmonary Embolism Response Team and Admitted from Local Emergency Department. [PDF]

J Clin Med
Jermakow M, Machowski M, Gałecka-Nowak M, Deutsch K, Il A, Imiela A, Karolak B, Perzanowska-Brzeszkiewicz K, Pacho S, Wójcik A, Roik M, Krakowian M, Łabyk A, Gołębiowski M, Pruszczyk P.   +14 more
europepmc   +1 more source

Mortality prediction after major surgery in a mixed population through machine learning: a multi‐objective symbolic regression approach

Anaesthesia, Volume 80, Issue 5, Page 551-560, May 2025.
Summary Introduction Understanding 1‐year mortality following major surgery offers valuable insights into patient outcomes and the quality of peri‐operative care. Few models exist that predict 1‐year mortality accurately. This study aimed to develop a predictive model for 1‐year mortality in patients undergoing complex non‐cardiac surgery using a novel
Pietro Arina, Davide Ferrari, Nicholas Tetlow, Amy Dewar, Robert Stephens, Daniel Martin, Ramani Moonesinghe, Vasa Curcin, Mervyn Singer, John Whittle, Evangelos B. Mazomenos   +10 more
wiley   +1 more source

Post-COVID-19 Condition and Pulmonary Embolism. [PDF]

J Multidiscip Healthc
Huang HP, Wang HW, Cheng CH, Chang YS, Yeh TK, Huang WH, Liu CW, Chang CH, Liu PY, Yen YC, Tseng CH.   +10 more
europepmc   +1 more source

Cardiovascular safety of testosterone therapy—Insights from the TRAVERSE trial and beyond: A position statement of the European Expert Panel for Testosterone Research

Andrology, EarlyView.
Abstract Introduction Testosterone therapy has become a cornerstone treatment for men with hypogonadism, offering significant benefits such as improved sexual function, mood, muscle mass, and bone density. However, concerns about its cardiovascular safety have historically tempered its use.
Michael Zitzmann, Giulia Rastrelli, Robert D Murray, David Edwards, Yacov Reisman, Preethi Mohan Rao, Alexander Sahi, Thomas Hugh Jones, Alberto Ferlin, Eleni Armeni, Emiliano Corpas, Jann‐Frederik Cremers, Janine David, Stefan Arver, Leen Antonio, Giovanni Corona   +15 more
wiley   +1 more source

Cryptogenic organizing pneumonia complicated by pulmonary embolism following glucocorticoid therapy: a case report. [PDF]

BMC Pulm Med
Liu D, Zhao L, Zhang X, Liu Y, Wu C.
europepmc   +1 more source

Postpartum maternal thrombophilia workup value in pregnancies with severe small for gestational age

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
The study investigates the prevalence and types of maternal thrombophilia among women who delivered a singleton newborn with a birthweight below the 3rd percentile, defined as severe small for gestational age. Data were collected from 733 patients, with 401 undergoing a postpartum thrombophilia workup.
Maëlig Abgral, Céline Desconclois, Sophie Prevot, Isabelle Monier, Raluca Sterpu, Alexandra Benachi, Alexandre J. Vivanti   +6 more
wiley   +1 more source

Can Systemic Inflammatory Markers Be Used in Pulmonary Embolism Risk Assessment in Patients with Acute Pulmonary Thromboembolism? [PDF]

J Inflamm Res
Özdemir L, Özdemir B, Gegin S, Aksu EA, Pazarlı AC.   +4 more
europepmc   +1 more source